EPO “Follow-On” Products In Europe Need Two Clinical Efficacy Trials, EMEA Says
This article was originally published in The Pink Sheet Daily
Executive Summary
European Medicines Agency draft guidance on registration requirements for biosimilar epoetin products says efficacy studies should include a “maintenance phase” and a “titration phase.” The guidelines also call for clinical safety data from at least 300 patients.